scholarly journals Expression of cetuximab biosimilar for development of Immunonanoparticle: Strategies and targets for drug delivery proposal towards treatment of prostate cancer

2021 ◽  
Author(s):  
José Vieira Neto ◽  
Claudia Pessoa
Keyword(s):  
Prostate Cancer ◽  
Drug Delivery

Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review

2017 ◽  
Vol 18 (11) ◽  
Author(s):  
Rohit R. Bhosale ◽  
H. V. Gangadharappa ◽  
Umme Hani ◽  
Riyaz Ali M. Osmani ◽  
Rudra Vaghela ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Novel Drug

Recent trends in carbon nanotubes based prostate cancer therapy: A biomedical hybrid for diagnosis and treatment

2021 ◽  
Vol 18 ◽  
Author(s):  
Raja Murugesan ◽  
Sureshkumar Raman
Keyword(s):  
Prostate Cancer ◽  
Carbon Nanotubes ◽  
Drug Delivery ◽  
Drug Loading ◽  
High Surface ◽  
High Surface Area ◽  
High Capacity ◽  
Chemical Properties ◽  
Diagnosis And Treatment ◽  
High Level

: At present treatment methods for cancer are limited, partially due to the solubility, poor cellular distribution of drug molecules and, the incapability of drugs to annoy the cellular barriers. Carbon nanotubes (CNTs) generally have excellent physio-chemical properties, which include high-level penetration into the cell membrane, high surface area and high capacity of drug loading by in circulating modification with bio-molecules, project them as an appropriate candidate to diagnose and deliver drugs to prostate cancer (PCa). Additionally, the chemically modified CNTs which have excellent 'Biosensing' properties therefore makes it easy for detecting PCa without fluorescent agent and thus targets the particular site of PCa and also, Drug delivery can accomplish a high efficacy, enhanced permeability with less toxic effects. While CNTs have been mainly engaged in cancer treatment, a few studies are focussed on the diagnosis and treatment of PCa. Here, we detailly reviewed the current progress of the CNTs based diagnosis and targeted drug delivery system for managing and curing PCa.

Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells

2017 ◽  
Vol 408 ◽  
pp. 164-173 ◽  
Author(s):  
O. Bashari ◽  
B. Redko ◽  
A. Cohen ◽  
G. Luboshits ◽  
G. Gellerman ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Drug Delivery ◽  
Cancer Cells ◽  
Drug Carrier ◽  
Peptide Drug ◽  
Prostate Cancer Cells

Nanoformulations for Targeted Drug Delivery to Prostate Cancer: An Overview

2018 ◽  
Vol 18 (8) ◽  
pp. 5171-5191 ◽  
Author(s):  
Soundararajan Hema ◽  
Selvarathinam Thambiraj ◽  
Dhesingh Ravi Shankaran
Keyword(s):  
Prostate Cancer ◽  
Drug Delivery ◽  
Targeted Drug Delivery ◽  
Targeted Drug

Advanced drug delivery systems in prostate cancer

2021 ◽  
pp. 197-206
Author(s):  
C. Sarath Chandran ◽  
Alan Raj ◽  
T.K. Shahin Muhammed
Keyword(s):  
Prostate Cancer ◽  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems

scholarly journals Prostate cancer relevant antigens and enzymes for targeted drug delivery

2014 ◽  
Vol 187 ◽  
pp. 118-132 ◽  
Author(s):  
Ashutosh Barve ◽  
Wei Jin ◽  
Kun Cheng
Keyword(s):  
Prostate Cancer ◽  
Drug Delivery ◽  
Targeted Drug Delivery ◽  
Targeted Drug
Sign in / Sign up

Export Citation Format

Share Document